Article
Transgenic Interleukin 10 Prevents Induction of Experimental Autoimmune Encephalomyelitis
15 Mar 1999
Abstract excerpt
The effectiveness of interleukin 10 (IL-10) in the treatment of autoimmune-mediated central nervous system inflammation is controversial. Studies of the model system, experimental autoimmune encephalomyelitis (EAE), using various routes, regimens, and delivery methods of IL-10 suggest that these variables may affect its immunoregulatory function. To study the influence of these factors on IL-10 regulation of EAE...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
